CLSD Clearside Biomedical Inc

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

$4.51
As of 06/21/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/02/2016
Outstanding shares:  57,578,725
Average volume:  7,318,182
Market cap:   $278,681,029
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    185063104
ISIN:        US1850631045
Sedol:      BZ6VT37
Valuation   (See tab for details)
PE ratio:   -11.46
PB ratio:   15.29
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy